Akselos
Venture Round in 2022
Akselos S.A., founded in 2011 and based in Lausanne, Switzerland, specializes in advanced engineering simulation software, specifically its Integra platform. This cloud-based solution allows engineering firms to create high-resolution digital twins of large-scale operational assets, enabling detailed analysis of structural integrity and hydrodynamic performance. Akselos's technology is particularly beneficial for asset-centric industries such as upstream oil and gas and offshore wind, where real-time monitoring and predictive maintenance are critical. The platform's patented algorithms provide simulations that are significantly faster than traditional methods, allowing for efficient design and management of critical infrastructure. Akselos also operates a subsidiary in Cambridge, Massachusetts, and maintains a representative office in Vietnam, underscoring its global presence in providing innovative simulation solutions.
ObvioHealth
Series B in 2021
ObvioHealth is a global digital health organization focused on enhancing clinical trials through innovative technology. The company provides a mobile clinical study application that facilitates site-less trial designs, enabling participants to engage in remote monitoring from their homes. This application supports continuous data collection between clinic visits, ensuring robust data acquisition and improved participant compliance. By utilizing features such as text messaging and chatbots, ObvioHealth fosters daily interaction with trial subjects, enhancing their involvement in the process. The platform also integrates seamlessly with various health devices, including smartwatches and activity trackers, which aids in collecting real-world data. Additionally, participants can manage lab visit scheduling and receive compensation through their connected accounts. By streamlining communication through chat or video, ObvioHealth significantly improves the clinical trial experience for both sponsors and participants, leading to faster recruitment and reduced trial completion times.
Global Growth
Series A in 2020
Global Growth is a multinational private investment firm that focuses on acquiring and investing in various sectors, including healthcare technology, communications, financial services, and business software. The company strategically targets businesses involved in insurance and annuities, media, market intelligence, and certification, offering services such as training, market research, advertising, and information services. By leveraging its expertise, Global Growth aims to enhance the performance and value of its portfolio companies while delivering strong returns to its investors.
Clovia is a lingerie brand that specializes in manufacturing and selling a diverse range of products, including fashion lingerie, innerwear, nightwear, and shapewear. Aimed at Indian women, Clovia addresses the need for stylish and comfortable undergarments, moving away from traditional one-size-fits-all options. The company operates over 200 stores across 50 locations, providing women with access to designer-quality lingerie at affordable prices. Clovia's focus on solution-based, premium products positions it as a modern alternative in the lingerie market, catering to the evolving preferences of its customers.
Lenddo International, established in 2011, operates an online platform enabling users to leverage their social network reputation for accessing local financial services. Headquartered in Hong Kong with offices in the Philippines, Colombia, and New York, Lenddo serves customers in Colombia and the Philippines, offering loans for education, debt consolidation, appliances, medical expenses, home improvements, or small businesses. It uses data from users' online social connections to assess creditworthiness, making financial services more accessible. As of October 2017, Lenddo operates as a subsidiary of EFL Global Ltd.